Search

Search Constraints

You searched for: Author/Creator Matsubara, Hisahiro

Search Results

1. 648. HYPOXIA-INDUCIBLE FACTOR 1α (HIF-1α) STIMULATES THE PROGRESSION OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA BY ACTIVATING THE WNT/β-CATENIN SIGNALLING PATHWAY. (24th September 2022)

2. A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial). Issue 32 (7th August 2020)

3. A randomized controlled, open‐label early phase II trial comparing incidence of FOLFIRI.3‐induced diarrhoea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer. (13th August 2019)

5. An extremely high bioavailability of orally administered vancomycin in a patient with severe colitis and renal insufficiency. Issue 12 (December 2017)

6. Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan. (December 2021)

7. Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma. Issue 4 (26th February 2018)

8. Anti‐FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer. Issue 2 (2nd January 2021)

9. Anti‐FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma. Issue 6 (20th May 2019)

10. Apparent diffusion coefficient by magnetic resonance cholangiopancreatography is useful for grading cholecystitis and surgery planning. Issue 2 (30th September 2022)